NIH-funded research R01 grant

Improving SYNGAP1 function to help with autism

Official title: Rescuing SYNGAP1 haploinsufficiency by redirecting alternative splicing

Funded at University of Chicago · NIH-11047659 · Data updated 2026-11-12

This study is looking at how changes in the SYNGAP1 gene affect autism and aims to find new ways to help people with these gene changes by fixing the proteins that are often low in their cells.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startApril 1, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$517,833
NIH project number5R01MH130594-03
Project IDNIH-11047659 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with autism spectrum disorders linked to SYNGAP1 mutations.

Less likely to help

Patients without SYNGAP1 mutations or those with other unrelated neurodevelopmental disorders may not benefit from this research.

What this research studies

This research focuses on understanding how changes in the SYNGAP1 gene contribute to autism and related disorders. By using innovative techniques to redirect the way this gene is spliced, the researchers aim to restore normal protein levels that are often deficient in individuals with SYNGAP1 mutations. The study involves both genetic approaches and the use of specialized oligonucleotides to target and modify the splicing process in cells derived from patients. Ultimately, the goal is to develop new therapeutic strategies that could improve outcomes for those affected by these genetic changes.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance SYNGAP1 protein expression, potentially improving symptoms for individuals with autism spectrum disorders.

How similar studies have gone: Previous research has shown promise in using splice-switching oligonucleotides for similar genetic conditions, indicating a potential for success in this approach.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Zhang, Xiaochang — University of Chicago
  • Study coordinator: Zhang, Xiaochang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.